Lets overcome cancer together
CancerLinQ, a sub-brand of ASCO, approached us with a desire to separate itself from the parent brand. As the brand grew, the team wanted to stand out on its own. We worked closely with the CancerLinQ team, conducting interviews and doing research, to clarify CancerLinQ’s value proposition and unique position in the marketplace. As a cancer data platform, CancerLinQ tapped into ASCOs extensive network and resources to synthesize vast amounts of data into actionable knowledge.
Insight
Oncologists don’t trust third party datasets. Yet, EHRs are too localized, not communicating between hospital networks. There is a disconnect between data providers and data users.
The Big Idea
We focused on outlining CancerLinQ’s shared journey and desired outcomes. By maintaining a higher standard, CancerlinQ positions all invested partners — researchers, healthcare providers, and patients on a path for success.